SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABMD - Replacement Heart System -- Ignore unavailable to you. Want to Upgrade?


To: High-Tech East who wrote (39)1/30/2001 4:50:58 PM
From: Lynn  Respond to of 147
 
ABMD rated a 'BUY' by Banc of America Securities
1/30/01 11:40 AM
Source: News.com

Mid-Day Viewpoints:

ABIOMED, INC.* (ABMD) BUY Price: $25.19 Target Price: $45

AbioMed gets FDA Green Light to Start Human Implants.

AbioMed received an FDA approval of its clinical trial plan (an IDE --
investigational device exemption) to test its total replacement heart
in humans.

The replacement heart, called the AbioCor, has been in countless
calves and has undergone rigorous bench testing and will soon be
“road tested”.

investor.cnet.com

Lynn



To: High-Tech East who wrote (39)1/30/2001 11:19:01 PM
From: Mark Johnson  Respond to of 147
 
Better than Yahoo......I don't think the market has yet recognized the scope of the FDA's fasttrack approval of the AbioCor......Abiomed has permission to REMOVE a human heart and replace it with a mechanical device....and the FDA has given the green light....pretty incredible stuff......The speed of the approval really took me by surprise...

Good luck Ken,

MJ